Moderna Partners with OpenAI to Revolutionize mRNA Medicine

Moderna, Inc. and OpenAI have announced a groundbreaking collaboration aimed at harnessing the transformative power of artificial intelligence (AI) in healthcare and business. This collaboration marks a significant step forward in leveraging AI technology to advance the development and delivery of mRNA medicines, paving the way for revolutionary advancements in healthcare.

A Visionary Collaboration for AI Innovation

Moderna, renowned for its digital-first approach and early adoption of machine learning, joins forces with OpenAI, a leader in AI research and development. With a shared vision of AI's potential to reshape the future of healthcare, the collaboration is poised to drive innovation and accelerate the delivery of life-changing mRNA medicines.

Stéphane Bancel, CEO of Moderna: "Just as the introduction of the personal computer in the 1980s changed the way we work and live, AI is on a path to completely transform our everyday lives - and OpenAI is helping to lead the way. Both our companies have shared values and are research-driven organizations pushing the boundaries of technology to drive transformation."

Sam Altman, CEO of OpenAI: "Moderna is leading the way by empowering all of its employees to use AI to tackle complex problems. We look forward to continuing to collaborate with Moderna to bring a new generation of medicines to patients in need."